1 2 Next

Self-reported difficulties with everyday function, cognitive symptoms and cognitive function in people with HIV.

Laverick, Rosanna; Haddow, Lewis; Daskalopoulou, Marina; More

JAIDS Journal of Acquired Immune Deficiency Syndromes ., Post Acceptance: June 07, 2017

Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV

De Luca, Andrea; Lorenzini, Patrizia; Castagna, Antonella; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(4):465-471, August 1, 2017.

HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection

Casetti, Rita; Pinnetti, Carmela; Sacchi, Alessandra; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(3):338-344, July 1, 2017.

Granulocytic Myeloid–Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level

Tumino, Nicola; Bilotta, Maria T.; Pinnetti, Carmela; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 74(5):575-582, April 15, 2017.

Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine: A Substudy of the...

Winston, Alan; Stöhr, Wolfgang; Antinori, Andrea; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 74(2):185-192, February 1, 2017.

Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study

van Lunzen, Jan; Pozniak, Anton; Gatell, Jose M.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 71(5):538-543, April 15, 2016.

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy

Di Biagio, Antonio; Cozzi-Lepri, Alessandro; Prinapori, Roberta; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 71(3):263-271, March 1, 2016.

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

Pinnetti, Carmela; Di Giambenedetto, Simona; Maggiolo, Franco; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 70(4):e147-e150, December 1, 2015.

Minimal Cognitive Impairment in UK HIV-Positive Men Who Have Sex With Men: Effect of Case Definitions and Comparison With the General Population and HIV-Negative Men

McDonnell, Jeffrey; Haddow, Lewis; Daskalopoulou, Marina; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 67(2):120-127, October 1, 2014.

Incidence, Timing, and Determinants of Bacterial Pneumonia Among HIV-Infected Patients: Data From the ICONA Foundation Cohort

Mussini, Cristina; Galli, Laura; Lepri, Alessandro C.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(3):339-345, July 1, 2013.

Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1–Infected Patients on Suppressive Antiretroviral Therapy: A Longitudinal Study

De Luca, Andrea; de Gaetano Donati, Katleen; Cozzi-Lepri, Alessandro; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 60(3):e98-e101, July 1, 2012.

Timed Short Messaging Service Improves Adherence and Virological Outcomes in HIV-1–Infected Patients With Suboptimal Adherence to Antiretroviral Therapy

Ammassari, Adriana; Trotta, Maria Paola; Shalev, Noga; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 58(4):e113-e115, December 1, 2011.

Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian Cohort

Vescini, Fabio; Cozzi-Lepri, Alessandro; Borderi, Marco; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 58(2):163-172, October 1, 2011.

Different Evolution of Genotypic Resistance Profiles to Emtricitabine Versus Lamivudine in Tenofovir-Containing Regimens

Svicher, Valentina; Alteri, Claudia; Artese, Anna; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 55(3):336-344, November 1, 2010.

Is There Any Potential for First-Line Etravirine Use? Analysis From a Large Data Set of Antiretroviral Therapy-Naive HIV-Infected Patients Undergoing Resistance Test

Zaccarelli, Mauro; Antinori, Andrea; Cozzi-Lepri, Alessandro; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 53(1):150-151, January 2010.

Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders

Tozzi, Valerio; Balestra, Pietro; Salvatori, Maria Flora; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 52(1):56-63, September 2009.

Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment: Prevalence and Risk Factors

Tozzi, Valerio; Balestra, Pietro; Bellagamba, Rita; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 45(2):174-182, June 1, 2007.

Neuroactive Antiretroviral Drugs Do Not Influence Neurocognitive Performance in Less Advanced HIV-Infected Patients Responding to Highly Active Antiretroviral Therapy

Giancola, Maria Letizia; Lorenzini, Patrizia; Balestra, Pietro; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 41(3):332-337, March 2006.

Selection of Antiretroviral Therapy Guided by Genotypic or Phenotypic Resistance Testing: An Open-Label, Randomized, Multicenter Study (PhenGen)

Saracino, Annalisa; Monno, Laura; Locaputo, Sergio; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 37(5):1587-1598, December 15, 2004.

1 2 Next